PTEN and neoplastic syndrome: Approximately 80% of patients with classically defined Cowden syndrome carry the PTEN gene [8], which acts as a negative regulator of the PI3-kinase signaling pathway by catalyzing the dephosphorylation of PIP3 [9]. PTEN hamartoma tumor syndrome incorporates several rare diseases that develop secondary to germline mutations within the PTEN gene.